Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV

The global pandemic of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in widespread social and economic disruption. Effective interventions are urgently needed for the prevention and treatment of COVID-19. Neutralizing monoclonal antibodies (mAbs) have d...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Wen, Wang, Junchao, Jiao, Shasha, Gu, Chenjian, Xu, Wei, Chen, Ben, Wang, Rongjuan, Chen, Huilin, Xie, Youhua, Wang, An, Li, Gang, Zeng, Dadi, Zhang, Jinchao, Zhang, Min, Wang, Shuang, Wang, Mingzhu, Gui, Xun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317929/
https://www.ncbi.nlm.nih.gov/pubmed/34313527
http://dx.doi.org/10.1080/19420862.2021.1953683

Ejemplares similares

Ejemplares similares